Insider Trading: Alkermes Plc (ALKS.O)

ALKS.O on Nasdaq

57.72USD
26 Dec 2014
Price Change (% chg)

$1.56 (+2.78%)
Prev Close
$56.16
Open
$56.21
Day's High
$57.79
Day's Low
$56.17
Volume
330,806
Avg. Vol
842,118
52-wk High
$59.69
52-wk Low
$38.49

Search Stocks
EHRICH ELLIOT W Options Exercised: 0
Trade Date: Wednesday, 16 Jan 2013 Price: 22.09
Title: Officer Shares Held: 16,579
Type Traded: Direct Net Change in Shares This Filing: -11,301

Institutional Holders

% Shares Owned: 97.45%
# of Holders: 283
Total Shares Held: 142,504,460
3 Mo. Net Change: 227,471
# New Positions: 24
# Closed Positions: 34
# Increased Positions: 122
# Reduced Positions: 126
# Net Buyers: -4

Officers & Directors

Name Age Since Current Position

Richard Pops

51 2011 Chairman of the Board, Chief Executive Officer

Shane Cooke

51 2011 President

James Frates

46 2011 Chief Financial Officer, Senior Vice President

Gordon Pugh

56 2011 Chief Operating Officer, Senior Vice President, Chief Risk Officer

Kathryn Biberstein

55 2011 Senior Vice President, Chief Compliance Officer, General Counsel, Secretary

Rebecca Peterson

38 Senior Vice President, Corporate Communications

Elliot Ehrich

55 2011 Senior Vice President - Research and Development, Chief Medical Officer

Michael Landine

60 2011 Senior Vice President - Corporate Development

Mark Stejbach

50 2012 Senior Vice President, Chief Commercial Officer

Paul Mitchell

61 2012 Lead Independent Director

Nancy Wysenski

56 2013 Director

David Anstice

65 2011 Independent Director

Floyd Bloom

77 2011 Independent Director

Robert Breyer

70 2011 Independent Director

Wendy Dixon

58 2011 Independent Director

Geraldine Henwood

60 2011 Independent Director
Search Stocks